WARNING: As this organisation lists one or more EP accredited lobbyists, it is highly improbable that its lobbying costs are lower than €10,000.
WARNING: The lobbying costs declared by this organisation are extraordinarily high and may therefore have been over-declared.
1,500,000€ - 1,749,999€
Lobbyists declared: 13.75 FTE (15)
WARNING: The number of full time equivalent lobbyists declared by this organisation are extraordinarily high and may therefore have been over-declared.
Lobbyists with EP accreditation: 0
Meetings with European Commission: 1
Lobbying costs over the years:
Registration on EU Transparency Register
Goals / Remit
Incisive Health is a leading force in health policy and communications. In a healthcare environment that is noisy, changing rapidly and where decision-makers are under intense pressure, policy communications need to be incisive to make an impact.
Our work in Brussels focuses on supporting pan-European healthcare campaigns, engaging in Europe-wide clinical advocacy and leading policy communications in areas of EU competence.
Our team is made up of people with extensive experience of the European Commission and the European Parliament, and has a close knowledge of the EU regulatory landscape and how it impacts on healthcare delivery in EU member states.
We know how to cut through the noise and competing priorities to deliver results that enhance our clients' businesses and reputations and – ultimately – improve healthcare for patients.
Incisive Health provides strategic advice on EU policy developments and on engagement with the EU policymaking process in the public health field. We also support pan-European campaigns to improve patient care across EU member states. Our focus is on healthcare and public health matters in the EU regulatory environment and other issues - such as those affecting the economy, enterprise, information, the internal market, research and technology, and trade - to the extent that they impact these matters. As such, we work with EU policymakers on topics such as access to medicines, pharmaceutical policy, cross-border healthcare, patients’ rights and safety, digital health, market access issues, intellectual property rights, health funding, innovation, research and development in health, the impact of other EU policies on health. Incisive health works on EU policies related to healthcare and public health matters including on initiatives and legislative files on the following topics: - access to medicines, - pharmaceutical policy, - cross-border healthcare, - patients’ rights and safety, - digital health, - market access issues, - intellectual property rights, - health funding, - innovation, research and development in health, - the impact of other EU policies on health.
51 Welbeck Street
London W1G 9HL
Tel: 44 02034356100
Avenue Louise 54
Tel: 32 028939739
Lobbyists with EP accreditation
Person in charge of EU relations
Person with legal responsibility
Incisive Health is a member of the Public Affairs Board, which is the self-regulatory body for public affairs professionals in the United Kingdom.
Incisive Health is also a member of the European Public Affairs Consultancies’ Association which is the representative trade body for public affairs consultancies working with EU institution
Procurement from EU institutions
Grants from EU institutions
Total public financing
Other financial information
Clients generating a turnover of 200000-299999 €
Astellas Pharma Europe
Clients generating a turnover of 100000-199999 €
European Federation of Pharmaceutical Industries and Associations
Global Blood Therauptics
Clients generating a turnover of 50000-99999 €
Plasma Protein Therapeutics Association
Clients generating a turnover of 25000-49999 €
Clients generating a turnover of 10000-24999 €
European Federation of Neurological Associations
European Brain Council
Clients generating a turnover of 0-9999 €
There are no notes attached to this organisation.
Expert groups (European Commission)
Intergroups (European Parliament)
Industry forums (European Parliament)
Meetings with European Commission1 meetings found.
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't publish information about such meetings. All information below comes from European Commission web pages.
- 23 Jul 2021 - Director-General Roberto Viola - EU Action Plan for Better Cardiovascular Health (DG Communications Networks, Content and Technology)